Literature DB >> 21030981

PHF6 mutations in adult acute myeloid leukemia.

P Van Vlierberghe1, J Patel, O Abdel-Wahab, C Lobry, C V Hedvat, M Balbin, C Nicolas, A R Payer, H F Fernandez, M S Tallman, E Paietta, A Melnick, P Vandenberghe, F Speleman, I Aifantis, J Cools, R Levine, A Ferrando.   

Abstract

Loss of function mutations and deletions encompassing the plant homeodomain finger 6 (PHF6) gene are present in about 20% of T-cell acute lymphoblastic leukemias (ALLs). Here, we report the identification of recurrent mutations in PHF6 in 10/353 adult acute myeloid leukemias (AMLs). Genetic lesions in PHF6 found in AMLs are frameshift and nonsense mutations distributed through the gene or point mutations involving the second plant homeodomain (PHD)-like domain of the protein. As in the case of T-ALL, where PHF6 alterations are found almost exclusively in males, mutations in PHF6 were seven times more prevalent in males than in females with AML. Overall, these results identify PHF6 as a tumor suppressor gene mutated in AML and extend the role of this X-linked tumor suppressor gene in the pathogenesis of hematologic tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030981      PMCID: PMC3878659          DOI: 10.1038/leu.2010.247

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  31 in total

1.  Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias.

Authors:  Pieter Van Vlierberghe; Jules P P Meijerink; Ronald W Stam; Wendy van der Smissen; Elisabeth R van Wering; H Berna Beverloo; Rob Pieters
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

2.  Molecular characterization of acute myeloid leukemia.

Authors:  Konstanze Döhner; Hartmut Döhner
Journal:  Haematologica       Date:  2008-07       Impact factor: 9.941

3.  Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.

Authors:  M Kawamura; H Ohnishi; S X Guo; X M Sheng; M Minegishi; R Hanada; K Horibe; T Hongo; Y Kaneko; F Bessho; M Yanagisawa; T Sekiya; Y Hayashi
Journal:  Leuk Res       Date:  1999-02       Impact factor: 3.156

Review 4.  Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

Authors:  A Renneville; C Roumier; V Biggio; O Nibourel; N Boissel; P Fenaux; C Preudhomme
Journal:  Leukemia       Date:  2008-02-21       Impact factor: 11.528

5.  Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.

Authors:  Brian V Balgobind; Pieter Van Vlierberghe; Ans M W van den Ouweland; H Berna Beverloo; Joan N R Terlouw-Kromosoeto; Elisabeth R van Wering; Dirk Reinhardt; Martin Horstmann; Gertjan J L Kaspers; Rob Pieters; C Michel Zwaan; Marry M Van den Heuvel-Eibrink; Jules P P Meijerink
Journal:  Blood       Date:  2008-01-02       Impact factor: 22.113

6.  The clinical picture of the Börjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations.

Authors:  G Turner; K M Lower; S M White; M Delatycki; A K Lampe; M Wright; J Clayton Smith; B Kerr; S Schelley; H E Hoyme; B B A De Vries; T Kleefstra; M Grompe; B Cox; J Gecz; M Partington
Journal:  Clin Genet       Date:  2004-03       Impact factor: 4.438

7.  Protein and gene expression analysis of Phf6, the gene mutated in the Börjeson-Forssman-Lehmann Syndrome of intellectual disability and obesity.

Authors:  Anne K Voss; Robin Gamble; Caitlin Collin; Cheryl Shoubridge; Mark Corbett; Jozef Gécz; Tim Thomas
Journal:  Gene Expr Patterns       Date:  2007-07-06       Impact factor: 1.224

8.  Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.

Authors:  Elisabeth Paietta; Adolfo A Ferrando; Donna Neuberg; John M Bennett; Janis Racevskis; Hillard Lazarus; Gordon Dewald; Jacob M Rowe; Peter H Wiernik; Martin S Tallman; A Thomas Look
Journal:  Blood       Date:  2004-03-25       Impact factor: 22.113

9.  Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

Authors:  Felicitas Thol; Frederik Damm; Katharina Wagner; Gudrun Göhring; Brigitte Schlegelberger; Dieter Hoelzer; Michael Lübbert; Wolfgang Heit; Lothar Kanz; Günter Schlimok; Aruna Raghavachar; Walter Fiedler; Hartmut Kirchner; Gerhard Heil; Michael Heuser; Jürgen Krauter; Arnold Ganser
Journal:  Blood       Date:  2010-04-26       Impact factor: 25.476

10.  SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.

Authors:  Hilmar Quentmeier; Björn Schneider; Sonja Röhrs; Julia Romani; Margarete Zaborski; Roderick A F Macleod; Hans G Drexler
Journal:  J Hematol Oncol       Date:  2009-01-23       Impact factor: 17.388

View more
  61 in total

Review 1.  Molecular therapy for acute myeloid leukaemia.

Authors:  Catherine C Coombs; Martin S Tallman; Ross L Levine
Journal:  Nat Rev Clin Oncol       Date:  2015-12-01       Impact factor: 66.675

Review 2.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

Review 3.  Next-generation sequencing-based panel testing for myeloid neoplasms.

Authors:  Frank C Kuo; Fei Dong
Journal:  Curr Hematol Malig Rep       Date:  2015-06       Impact factor: 3.952

4.  PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation.

Authors:  Wenbin Xiao; Maheetha Bharadwaj; Max Levine; Noushin Farnhoud; Friederike Pastore; Bartlomiej M Getta; Anne Hultquist; Christopher Famulare; Juan S Medina; Minal A Patel; Qi Gao; Natasha Lewis; Janine Pichardo; Jeeyeon Baik; Brian Shaffer; Sergio Giralt; Raajit Rampal; Sean Devlin; Robert Cimera; Yanming Zhang; Maria E Arcila; Elli Papaemmanuil; Ross L Levine; Mikhail Roshal
Journal:  Blood Adv       Date:  2018-12-11

5.  Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.

Authors:  Qian Wang; Huiying Qiu; Hui Jiang; Lili Wu; Shasha Dong; Jinlan Pan; Wenjuan Wang; Nana Ping; Jing Xia; Aining Sun; Depei Wu; Yongquan Xue; Hans G Drexler; Roderick A F Macleod; Suning Chen
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

6.  DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study.

Authors:  Maddalena Paganin; Martina Pigazzi; Silvia Bresolin; Riccardo Masetti; Franca Fagioli; Sabina Chiaretti; Giovanni Cazzaniga; Franco Locatelli; Andrea Pession; Geertruy te Kronnie; Giuseppe Basso
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

7.  Context-specific tumor suppression by PHF6.

Authors:  Jennifer J Trowbridge
Journal:  Blood       Date:  2019-04-18       Impact factor: 22.113

8.  Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery.

Authors:  Veronique A J Smits; Ignacio Alonso-de Vega; Daniël O Warmerdam
Journal:  Cell Cycle       Date:  2020-07-30       Impact factor: 4.534

9.  Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.

Authors:  Zhonghua Liu; Fudong Li; Ke Ruan; Jiahai Zhang; Yide Mei; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

10.  PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis.

Authors:  Jiadong Wang; Justin Wai-chung Leung; Zihua Gong; Lin Feng; Xiaobing Shi; Junjie Chen
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.